FibroBiologics Inc. (NASDAQ: FBLG) announced it has released the first batch of its CYWC628 drug product for use in a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE